Clinical trial
Atrioventricular (AV) Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization vs. Medical Rate Control
NCT06833138 is registered in ClinicalTrials.gov with French Cardiology Society as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrioventricular (AV) Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization vs. Medical Rate Control
- Lead sponsor
- French Cardiology Society
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 10, 2025
- Completion date
- December 31, 2029
- Enrollment
- 266 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, persistent, heart failure with preserved ejection fraction